Mirror image stereoisomers of the major benzo[a]pyrene N2-dG adduct are bypassed by different lesion-bypass DNA polymerases in E. coli.

[1]  E. Loechler,et al.  Homology modeling of four Y-family, lesion-bypass DNA polymerases: the case that E. coli Pol IV and human Pol kappa are orthologs, and E. coli Pol V and human Pol eta are orthologs. , 2006, Journal of molecular graphics & modelling.

[2]  A. Nagalingam,et al.  Mutagenesis studies of the major benzo[a]pyrene N2-dG adduct in a 5'-TG versus a 5'-UG sequence: removal of the methyl group causes a modest decrease in the [G->T/G->A] mutational ratio. , 2005, Mutagenesis.

[3]  Z. Livneh,et al.  Quantitative Analysis of Translesion DNA Synthesis across a Benzo[a]pyrene-Guanine Adduct in Mammalian Cells , 2004, Journal of Biological Chemistry.

[4]  R. Fuchs,et al.  Defining the position of the switches between replicative and bypass DNA polymerases , 2004, The EMBO journal.

[5]  R. Fuchs,et al.  The biochemical requirements of DNA polymerase V-mediated translesion synthesis revisited. , 2004, Journal of molecular biology.

[6]  Jun Yin,et al.  A role for DNA polymerase V in G --> T mutations from the major benzo[a]pyrene N2-dG adduct when studied in a 5'-TGT sequence in E. coli. , 2004, DNA repair.

[7]  J. Strathern,et al.  Error-prone DNA polymerases: when making a mistake is the only way to get ahead. , 2003, Annual review of genetics.

[8]  R. Woodgate,et al.  Replication of a cis–syn thymine dimer at atomic resolution , 2003, Nature.

[9]  P. Hainaut,et al.  On the origin of G --> T transversions in lung cancer. , 2003, Mutation research.

[10]  J. Essigmann,et al.  High-fidelity in vivo replication of DNA base shape mimics without Watson–Crick hydrogen bonds , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Yanbin Zhang,et al.  Effects of base sequence context on translesion synthesis past a bulky (+)-trans-anti-B[a]P-N2-dG lesion catalyzed by the Y-family polymerase pol kappa. , 2003, Biochemistry.

[12]  Wei Yang.  Damage repair DNA polymerases Y. , 2003, Current opinion in structural biology.

[13]  Yanbin Zhang,et al.  Two-step error-prone bypass of the (+)- and (−)-trans-anti-BPDE-N2-dG adducts by human DNA polymerases η and κ , 2002 .

[14]  R. Fuchs,et al.  How DNA lesions are turned into mutations within cells? , 2002, Oncogene.

[15]  C. Iden,et al.  Efficient synthesis of the benzo[a]pyrene metabolic adducts of 2'-deoxyguanosine and 2'-deoxyadenosine and their direct incorporation into DNA. , 2002, Chemical research in toxicology.

[16]  Y. Shinkai,et al.  Polκ protects mammalian cells against the lethal and mutagenic effects of benzo[a]pyrene , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Yanbin Zhang,et al.  trans-Lesion Synthesis Past Bulky Benzo[a]pyrene Diol Epoxide N 2-dG and N 6-dA Lesions Catalyzed by DNA Bypass Polymerases* , 2002, The Journal of Biological Chemistry.

[18]  Yanbin Zhang,et al.  Activities of human DNA polymerase kappa in response to the major benzo[a]pyrene DNA adduct: error-free lesion bypass and extension synthesis from opposite the lesion. , 2002, DNA repair.

[19]  M. Radman,et al.  Specialized DNA Polymerases, Cellular Survival, and the Genesis of Mutations , 2002, Science.

[20]  R. Woodgate,et al.  Structure-based interpretation of missense mutations in Y-family DNA polymerases and their implications for polymerase function and lesion bypass. , 2002, DNA repair.

[21]  A. Grollman,et al.  Translesion synthesis by human DNA polymerase kappa on a DNA template containing a single stereoisomer of dG-(+)- or dG-(-)-anti-N(2)-BPDE (7,8-dihydroxy-anti-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene). , 2002, Biochemistry.

[22]  D. Jerina,et al.  Preferential Misincorporation of Purine Nucleotides by Human DNA Polymerase η Opposite Benzo[a]pyrene 7,8-Diol 9,10-Epoxide Deoxyguanosine Adducts* , 2002, The Journal of Biological Chemistry.

[23]  J. Wagner,et al.  Genetics of mutagenesis in E. coli: various combinations of translesion polymerases (Pol II, IV and V) deal with lesion/sequence context diversity. , 2002, DNA repair.

[24]  D. Jerina,et al.  Efficiency and Accuracy of SOS-induced DNA Polymerases Replicating Benzo[a]pyrene-7,8-diol 9,10-Epoxide A and G Adducts* , 2002, The Journal of Biological Chemistry.

[25]  E. Koonin,et al.  Eukaryotic DNA Polymerases: Proposal for a Revised Nomenclature* , 2001, The Journal of Biological Chemistry.

[26]  M. Yamada,et al.  Roles of chromosomal and episomal dinB genes encoding DNA pol IV in targeted and untargeted mutagenesis in Escherichia coli , 2001, Molecular Genetics and Genomics.

[27]  Z. Wang.  Translesion synthesis by the UmuC family of DNA polymerases. , 2001, Mutation research.

[28]  T. Kunkel,et al.  The Y-family of DNA polymerases. , 2001, Molecular cell.

[29]  Yanbin Zhang,et al.  Error-prone lesion bypass by human DNA polymerase eta. , 2000, Nucleic acids research.

[30]  J. Wagner,et al.  All three SOS‐inducible DNA polymerases (Pol II, Pol IV and Pol V) are involved in induced mutagenesis , 2000, The EMBO journal.

[31]  R. Fuchs,et al.  The processing of a Benzo(a)pyrene adduct into a frameshift or a base substitution mutation requires a different set of genes in Escherichia coli , 2000, Molecular microbiology.

[32]  Satya Prakash,et al.  Eukaryotic polymerases ι and ζ act sequentially to bypass DNA lesions , 2000, Nature.

[33]  Robert E. Johnson,et al.  Accuracy of thymine-thymine dimer bypass by Saccharomyces cerevisiae DNA polymerase eta. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Satya Prakash,et al.  Fidelity of Human DNA Polymerase η* , 2000, The Journal of Biological Chemistry.

[35]  Fenghua Yuan,et al.  Specificity of DNA Lesion Bypass by the Yeast DNA Polymerase η* , 2000, The Journal of Biological Chemistry.

[36]  Robert E. Johnson,et al.  Fidelity and Processivity of Saccharomyces cerevisiae DNA Polymerase η* , 1999, The Journal of Biological Chemistry.

[37]  D. Jerina,et al.  Characterization of the mutational profile of (+)-7R,8S-dihydroxy-9S, 10R-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene at the hypoxanthine (guanine) phosphoribosyltransferase gene in repair-deficient Chinese hamster V-H1 cells. , 1999, Carcinogenesis.

[38]  Robert E. Johnson,et al.  Bridging the gap: a family of novel DNA polymerases that replicate faulty DNA. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Essigmann,et al.  Context-dependent mutagenesis by DNA lesions. , 1999, Chemistry & biology.

[40]  Robert E. Johnson,et al.  hRAD30 mutations in the variant form of xeroderma pigmentosum. , 1999, Science.

[41]  Chikahide Masutani,et al.  The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η , 1999, Nature.

[42]  D. Jerina,et al.  The ratio of deoxyadenosine to deoxyguanosine adducts formed by (+)-(7R,8S,9S,10R)-7,8-dihydroxy-9,10-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene in purified calf thymus DNA and DNA in V-79 cells is independent of dose. , 1999, International journal of oncology.

[43]  Robert E. Johnson,et al.  Efficient bypass of a thymine-thymine dimer by yeast DNA polymerase, Poleta. , 1999, Science.

[44]  N. Geacintov,et al.  The major, N2-dG adduct of (+)-anti-B[a]PDE induces G-->A mutations in a 5'-AGA-3' sequence context. , 1999, Carcinogenesis.

[45]  N. Geacintov,et al.  How stereochemistry affects mutagenesis by N2-deoxyguanosine adducts of 7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene: configuration of the adduct bond is more important than those of the hydroxyl groups. , 1997, Biochemistry.

[46]  N. Geacintov,et al.  The major, N2-dG adduct of (+)-anti-B[a]PDE shows a dramatically different mutagenic specificity (predominantly, G --> A) in a 5'-CGT-3' sequence context. , 1997, Biochemistry.

[47]  N. Geacintov,et al.  Sequence specific mutagenesis of the major (+)-anti-benzo[a]pyrene diol epoxide-DNA adduct at a mutational hot spot in vitro and in Escherichia coli cells. , 1997, Chemical research in toxicology.

[48]  E. Cavalieri,et al.  Expanded analysis of benzo[a]pyrene-DNA adducts formed in vitro and in mouse skin: their significance in tumor initiation. , 1996, Chemical research in toxicology.

[49]  J. Pelling,et al.  Relating aromatic hydrocarbon-induced DNA adducts and c-H-ras mutations in mouse skin papillomas: the role of apurinic sites. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[50]  N. Geacintov,et al.  The major, N2-Gua adduct of the (+)-anti-benzo[a]pyrene diol epoxide is capable of inducing G-->A and G-->C, in addition to G-->T, mutations. , 1995, Biochemistry.

[51]  T. Krugh,et al.  Structural characterization of a (+)-trans-anti-benzo[a]pyrene-DNA adduct using NMR, restrained energy minimization, and molecular dynamics. , 1995, Biochemistry.

[52]  S. Y. Zhang,et al.  Murine squamous cell carcinoma cell lines produced by a complete carcinogenesis protocol with benzo[a]pyrene exhibit characteristic p53 mutations and the absence of H-ras and cyl 1/cyclin D1 abnormalities. , 1994, Carcinogenesis.

[53]  E. Loechler,et al.  Mutational specificity of the (+)-anti-diol epoxide of benzo[a]pyrene in a supF gene of an Escherichia coli plasmid: DNA sequence context influences hotspots, mutagenic specificity and the extent of SOS enhancement of mutagenesis. , 1993, Carcinogenesis.

[54]  E. Loechler,et al.  Mutagenesis by the (+)-anti-diol epoxide of benzo[a]pyrene: what controls mutagenic specificity? , 1993, Biochemistry.

[55]  M. Benasutti,et al.  Mutagenesis by (+)-anti-B[a]P-N2-Gua, the major adduct of activated benzo[a]pyrene, when studied in an Escherichia coli plasmid using site-directed methods. , 1992, Carcinogenesis.

[56]  D. Patel,et al.  Influence of benzo[a]pyrene diol epoxide chirality on solution conformations of DNA covalent adducts: the (-)-trans-anti-[BP]G.C adduct structure and comparison with the (+)-trans-anti-[BP]G.C enantiomer. , 1992, Biochemistry.

[57]  D. Patel,et al.  Solution conformation of the major adduct between the carcinogen (+)-anti-benzo[a]pyrene diol epoxide and DNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[58]  R. Woodgate,et al.  Levels of chromosomally encoded Umu proteins and requirements for in vivo UmuD cleavage , 1991, Molecular and General Genetics MGG.

[59]  J. E. Leclerc,et al.  Mutation frequency and spectrum resulting from a single abasic site in a single-stranded vector. , 1990, Nucleic acids research.

[60]  D. Grunberger,et al.  Molecular Biology of Mutagens and Carcinogens , 1983, Springer US.

[61]  D. Phillips.  Fifty years of benzo(a)pyrene , 1983, Nature.

[62]  A. Conney,et al.  Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. , 1982, Cancer research.

[63]  R. Niessner,et al.  polynuclear aromatic hydrocarbons , 2017 .

[64]  T. Kunkel,et al.  Functions of DNA polymerases. , 2004, Advances in protein chemistry.

[65]  J. Wagner,et al.  Properties and functions of Escherichia coli: Pol IV and Pol V. , 2004, Advances in protein chemistry.

[66]  G. Maga,et al.  Eukaryotic DNA polymerases. , 2002, Annual review of biochemistry.

[67]  M. Goodman.  Error-prone repair DNA polymerases in prokaryotes and eukaryotes. , 2002, Annual review of biochemistry.

[68]  E. Friedberg.  Why do cells have multiple error‐prone DNA polymerases? , 2001, Environmental and molecular mutagenesis.

[69]  C. Cooper,et al.  Chemical Carcinogenesis and Mutagenesis I , 1990, Handbook of Experimental Pharmacology.

[70]  A. Dipple,et al.  Polycyclic aromatic hydrocarbon carcinogens. , 1990, Progress in clinical and biological research.

[71]  A. Balmain,et al.  Oncogene activation in chemical carcinogenesis. , 1988, Advances in cancer research.

[72]  P. Grasso.  Carcinogens in Food , 1983 .

[73]  J. Lodge.  Chemical carcinogens: ACS monograph 173: Ed. Charles E. Searle, American Chemical Society, Washington, D.C., 1976, pp. xxvii + 788. Price $67.50 , 1977 .